128 related articles for article (PubMed ID: 1654399)
1. Ubiquitin-immunoreactive dystrophic neurites in Down's syndrome brains.
Mattiace LA; Kress Y; Davies P; Ksiezak-Reding H; Yen SH; Dickson DW
J Neuropathol Exp Neurol; 1991 Sep; 50(5):547-59. PubMed ID: 1654399
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects.
Dickson DW; Wertkin A; Kress Y; Ksiezak-Reding H; Yen SH
Lab Invest; 1990 Jul; 63(1):87-99. PubMed ID: 2165197
[TBL] [Abstract][Full Text] [Related]
3. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
Ikeda S; Allsop D; Glenner GG
Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin immunoelectron microscopy of dystrophic neurites in cerebellar senile plaques of Alzheimer's disease.
Dickson DW; Wertkin A; Mattiace LA; Fier E; Kress Y; Davies P; Yen SH
Acta Neuropathol; 1990; 79(5):486-93. PubMed ID: 2158201
[TBL] [Abstract][Full Text] [Related]
5. Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains.
Ikeda S; Yanagisawa N; Allsop D; Glenner GG
Lab Invest; 1989 Jul; 61(1):133-7. PubMed ID: 2473275
[TBL] [Abstract][Full Text] [Related]
6. The developmental and aging changes of Down's syndrome cell adhesion molecule expression in normal and Down's syndrome brains.
Saito Y; Oka A; Mizuguchi M; Motonaga K; Mori Y; Becker LE; Arima K; Miyauchi J; Takashima S
Acta Neuropathol; 2000 Dec; 100(6):654-64. PubMed ID: 11078217
[TBL] [Abstract][Full Text] [Related]
7. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
[TBL] [Abstract][Full Text] [Related]
8. The cortical neuritic pathology of Huntington's disease.
Jackson M; Gentleman S; Lennox G; Ward L; Gray T; Randall K; Morrell K; Lowe J
Neuropathol Appl Neurobiol; 1995 Feb; 21(1):18-26. PubMed ID: 7770116
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease.
Lippa CF; Schmidt ML; Lee VM; Trojanowski JQ
Ann Neurol; 1999 Mar; 45(3):353-7. PubMed ID: 10072050
[TBL] [Abstract][Full Text] [Related]
10. Age-related ubiquitin deposits in dystrophic neurites: an immunoelectron microscopic study.
Migheli A; Attanasio A; Pezzulo T; Gullotta F; Giordana MT; Schiffer D
Neuropathol Appl Neurobiol; 1992 Feb; 18(1):3-11. PubMed ID: 1315932
[TBL] [Abstract][Full Text] [Related]
11. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
[TBL] [Abstract][Full Text] [Related]
12. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
[TBL] [Abstract][Full Text] [Related]
13. Down's syndrome in middle age. Topographical distribution and immunoreactivity of brain lesions in an autopsied patient.
Yoshimura N; Kubota S; Fukushima Y; Kudo H; Ishigaki H; Yoshida Y
Acta Pathol Jpn; 1990 Oct; 40(10):735-43. PubMed ID: 1963256
[TBL] [Abstract][Full Text] [Related]
14. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome.
Teller JK; Russo C; DeBusk LM; Angelini G; Zaccheo D; Dagna-Bricarelli F; Scartezzini P; Bertolini S; Mann DM; Tabaton M; Gambetti P
Nat Med; 1996 Jan; 2(1):93-5. PubMed ID: 8564851
[TBL] [Abstract][Full Text] [Related]
15. Developmental immunohistochemistry of growth inhibitory factor in normal brains and brains of patients with Down syndrome.
Arai Y; Uchida Y; Takashima S
Pediatr Neurol; 1997 Sep; 17(2):134-8. PubMed ID: 9367293
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition.
Royston MC; McKenzie JE; Gentleman SM; Sheng JG; Mann DM; Griffin WS; Mrak RE
Neuropathol Appl Neurobiol; 1999 Oct; 25(5):387-93. PubMed ID: 10564528
[TBL] [Abstract][Full Text] [Related]
17. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.
Cras P; Kawai M; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7552-6. PubMed ID: 1652752
[TBL] [Abstract][Full Text] [Related]
18. Colocalization of lysosomal hydrolase and beta-amyloid in diffuse plaques of the cerebellum and striatum in Alzheimer's disease and Down's syndrome.
Cataldo AM; Barnett JL; Mann DM; Nixon RA
J Neuropathol Exp Neurol; 1996 Jun; 55(6):704-15. PubMed ID: 8642396
[TBL] [Abstract][Full Text] [Related]
19. HB-GAM is a cytokine present in Alzheimer's and Down's syndrome lesions.
Wisniewski T; Lalowski M; Baumann M; Rauvala H; Raulo E; Nolo R; Frangione B
Neuroreport; 1996 Jan; 7(2):667-71. PubMed ID: 8730853
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical profile of neurofibrillary tangles in Down's syndrome patients of different ages.
Mann DM; Prinja D; Davies CA; Ihara Y; Delacourte A; Défossez A; Mayer RJ; Landon M
J Neurol Sci; 1989 Sep; 92(2-3):247-60. PubMed ID: 2553874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
